Biochemical Engineering Special Interest Group
biological engineering professionals
06 September 2017

Tiny Bicycle Therapeutics Signs a $424M R&D Pact With Bioverativ

Bioverativ, Inc., the Biogen (BIIB) hemophilia drug spinoff company, and England-based Bicycle Therapeutics Ltd. struck a collaborative agreement to develop therapies for the treatment of hemophilia and sickle cell disease. The two companies will focus on Bicycle’s proprietary bicyclic peptides platform, from which the company derives its name. Bicycles are a novel class of small molecule medicines designed to overcome many of the limitations of existing drug modalities, the company said. Source: Biospace 6/9/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).